Remove Confidentiality Remove Patent Application Remove Workshop
article thumbnail

SpicyIP Weekly Review (March 13- March 18)

SpicyIP

In yet another order dealing with unreasoned rejections of a patent application, the Delhi High Court comes down heavily on the Indian Patent Office. Praharsh and Swaraj write about this order, underscoring the role played by well-reasoned orders in the appeals before the high court and patent bargain.

Art 104
article thumbnail

Impact of other related Intellectual Property rights on the Pharmaceutical Industry

IIPRD

Section 3 of the Patents Act lists statutorily non-patentable inventions, which pose a challenge to patentability depending on the subject matter claimed. In summary, a patent application for a medical device in India is often objected to under Sections 3(i), (f), and (k).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monthly Wrap Up (March 12, 2023): Noteworthy Trade Secret and Restrictive Covenant Cases, Developments and Posts

LexBlog IP

District Court for the Southern District of Ohio Judge Timothy Black rejected arguments that a state court declaratory relief action over the ownership of several disputed patent applications involved federal patent or trade secret claims and ruled that it belonged in state court.

article thumbnail

The Biden Executive Order Curtailing Non-Competes: Why It May Be Bad for Small Companies

LexBlog IP

On January 9, 2020, the FTC held a public workshop to consider whether the FTC should issue a rule that would limit or forbid the use of non-competes in employment contracts and subsequently invited submissions from interested parties. Will it include non-solicitation and confidentiality agreements, or will it be confined to non-competes?